Search Results for: Over The Counter stromecto

CMS proposes Part D concessions be made at the pharmacy counter

The Pharmaceutical Care Management Association, which represents PBMs, has defended DIR fees as appropriate and based on pharmacy performance. “We are currently reviewing the proposed rule. However, previous point-of-sale proposals in Medicare have not advanced because they significantly increase Medicare spending,” said Greg Lopes, a spokesperson for PCMA.

Read More »

Direct and Indirect Remuneration (DIR)

America’s pharmacy benefit managers (PBMs) are dedicated to controlling drug costs by encouraging competition among drug manufacturers and pharmacies and incentivizing consumers to take the most costeffective, clinically appropriate medications. PBMs facilitate patient pharmacy care management and provide real-time information
Read More »

Drug Abuse Prevention

PCMA supports the creation of “Safe Pharmacies” in Medicare Part D for Controlled Prescription Drugs. The creation of “Safe Pharmacies,” or a “Lock-In” program in Part D for controlled substances, will allow Part D plans to require at-risk beneficiaries to
Read More »

The Pharmacy Benefit Brief | April 2022

Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. P&T COMMITTEES FOLLOW THE SCIENCE… Covering effective drugs for the broad

Read More »

PCMA Applauds House Passage of Bill Curbing Opioid Epidemic

(Washington, D.C.) — Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare. This is an important step in the fight against America’s

Read More »